| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.63▼ | 10.61▲ | 10.61▲ | 10.68▼ | 10.57▲ |
| MA10 | 10.62▲ | 10.62▲ | 10.63▼ | 10.64▼ | 10.51▲ |
| MA20 | 10.62▲ | 10.65▼ | 10.67▼ | 10.62▲ | 10.22▲ |
| MA50 | 10.66▼ | 10.64▼ | 10.62▲ | 10.52▲ | 10.19▲ |
| MA100 | 10.66▼ | 10.61▲ | 10.61▲ | 10.21▲ | 10.47▲ |
| MA200 | 10.62▲ | 10.58▲ | 10.53▲ | 10.18▲ | 10.79▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | -0.004▼ | -0.011▼ | -0.002▼ | 0.061▲ |
| RSI | 47.961▼ | 46.941▼ | 47.907▼ | 53.468▲ | 62.027▲ |
| STOCH | 77.778 | 45.000 | 14.931▼ | 58.506 | 82.931▲ |
| WILL %R | -25.000 | -71.875 | -71.875 | -55.130 | -14.812▲ |
| CCI | 30.280 | -22.428 | -49.682 | 29.557 | 85.850 |
|
Monday, October 20, 2025 11:25 PM
NovaBay Pharmaceuticals (NYSE:NBY) has formally regained compliance with the NYSE American's continued listing standards, successfully resolving deficiencies first cited in April and May 2024. The ...
|
|
Wednesday, October 15, 2025 07:17 AM
Biotechnology company bioAffinity Technologies (NASDAQ:BIAF) said on Wednesday that it has regained compliance with Nasdaq's all applicable continued listing requirements. In a letter dated October 14 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 10.69 | 10.718 | 10.57 | 10.63 | 140,500 |
| 13/11/25 | 10.72 | 10.74 | 10.59 | 10.74 | 153,355 |
| 12/11/25 | 10.76 | 10.77 | 10.70 | 10.72 | 111,422 |
| 11/11/25 | 10.65 | 10.8143 | 10.6125 | 10.73 | 221,992 |
| 10/11/25 | 10.59 | 10.6199 | 10.4845 | 10.60 | 85,095 |
| 07/11/25 | 10.56 | 10.62 | 10.48 | 10.54 | 126,351 |
| 06/11/25 | 10.65 | 10.685 | 10.545 | 10.59 | 101,915 |
| 05/11/25 | 10.59 | 10.70 | 10.55 | 10.63 | 196,379 |
| 04/11/25 | 10.69 | 10.70 | 10.51 | 10.59 | 207,913 |
| 03/11/25 | 10.65 | 10.65 | 10.565 | 10.65 | 140,100 |
|
|
||||
|
|
||||
|
|